Lanthanide-based resonance energy transfer (LRET) is an established method for measuring or detecting proximity between a luminescent lanthanide (energy donor) and an organic fluorophore (energy acceptor). Because resonance energy transfer is a distance-dependent phenomenon that increases in efficiency to the 6th power of the distance between the donor and the acceptor, assay systems are often designed to minimize donor-acceptor distances. However, the authors show that because of the R 6 relationship between transfer efficiency and sensitized emission lifetime, energy transfer can be difficult to measure in a time-gated manner when the donor-acceptor distance is small relative to the Förster radius. In such systems, the advantages inherent in time-resolved, ratiometric measurements are lost but can be regained by designing the system such that the average donor-acceptor distance is increased. (Journal of Biomolecular Screening 2006:439-443) 
F ÖRSTER RESONANCE ENERGY TRANSFER (FRET) using a lanthanide ion as the donor species is an established technique for measuring distances between labeled residues in proteins 1 or as the basis for assays that detect proximity between a donor/acceptor pair. 2 Because chelated lanthanide ions can have fluorescent lifetimes ranging from hundreds of milliseconds to several microseconds, lanthanide-based resonance energy transfer (LRET, also referred to as time-resolved FRET or TR-FRET) assays are ideal for screening large compound libraries for biological activity in a high-throughput setting. Such compound libraries often contain a number of autofluorescent or precipitated compounds that can cause interference (via fluorescence emission or scattered light) in standard fluorescent assay formats. Whereas such interferences occur on the low-nanosecond timescale (similar to the lifetime of standard organic fluorophores), LRET-based measurements can be made in a gated (or "time-resolved") detection format after these interfering signals have decayed to negligible levels.
An additional, important feature of LRET-based assays is the ability to correct for inner-filter effects caused by compounds that absorb light at the UV wavelengths used to excite the lanthanide chelate. Because such compounds will cause a decrease in the intensity of both the donor and acceptor emission signals, "ratioing" the acceptor emission signal to that of the donor emission signal 3 corrects for this interference. 4 The efficiency of energy transfer (E) between a pair of molecules participating in FRET is given by the Förster equation:
where R is the distance between the FRET partners and R 0 , the Förster radius, is the distance at which energy transfer is 50% efficient. 5 The efficiency of energy transfer can be experimentally determined from the lifetime of the donor species in the presence and absence of the acceptor from the following equation:
where τ DA and τ D are the lifetimes of the donor species in the presence and absence of acceptor, respectively. By writing equation (2) as
it becomes explicit that just as energy transfer efficiency rapidly increases as donor-acceptor distance decreases, the lifetime of the donor (as well as the sensitized emission of the short lifetime acceptor) rapidly decreases. 6 In the context of a gated intensity measurement to detect donor-acceptor proximity (as is performed for TR-FRET assays when using commonly available commercial high-throughput screening [HTS] instrumentation), an important consequence of this relationship is that in systems in which donor-acceptor distances are small relative to R 0 , the energy transfer may be too rapid to efficiently measure within the detection window. Figure 1 illustrates the consequences of a decreased sensitized emission lifetime as the distance between donor and acceptor decreases. Panel A models sensitized emission from a 1st-order decay based on a τ D of 2100 µs typical of triethylenepentaminehexanoic acid (TTHA)-based terbium chelates at different fixed donor-acceptor distances. 7 By integrating the area under the decay curve within a 200-µs detection window, following a 100-µs delay, it becomes clear (panel B) that in a gated intensity measurement, efficient resonance energy transfer (RET) will produce a signal similar to that seen in the absence of RET. Because of the inverse R 6 relationship between donor-acceptor distance and emission lifetime, shortening the delay prior to measurement results in only a minor leftward shift in the donoracceptor distance that yields maximum signal. For example, lowering the delay to 20 µs (lower than could be achieved without interference from flashlamp tailing) results in a shift of only 5 nm in terms of "optimal" donor-acceptor distance. An additional consequence that can be seen from Figure 1 is that, in a gated intensity measurement, a FRET-dependent signal is seen only within a limited range of donor-acceptor distances.
We experimentally validated these predictions in an LRETbased protease assay designed to detect beta-amyloid cleaving enzyme (BACE) activity, as outlined in Figure 2 . BACE is a key enzyme involved in the production of amyloid β-peptides found in extracellular amyloid plaques of Alzheimer disease. 8 To assay BACE-catalyzed cleavage of a peptide corresponding to the cleavage site in the Swedish mutation 9 of BACE substrate APP, 2 peptides were synthesized (EVNLDAEF, cleavage between residues L and D). Each peptide contained an N-terminal fluorescein and either a C-terminal cysteine that was directly labeled with maleimide-functionalized CS124-TTHA-based Tb chelate (1b) or a C-terminal lysine to which a biotin moiety was attached to the side chain ε-amino group (1a). Peptide 1b was designed to measure RET between a narrowly spaced donor-acceptor pair, whereas 1a was used to detect RET via interaction with a Tb-labeled streptavidin or Tblabeled antibiotin antibody. A 9-residue peptide has a length on the order of 13 to 31 Å (based on helical or extended structure), substantially less than the 49-Å R 0 value for the Tb-fluorescein RET pair. In contrast, streptavidin is a 55-kD protein with dimensions of approximately 54 × 58 × 48 Å, 10 The time-gated emission spectra (200-µs data collection following a 100-µs postexcitation delay) of 125 nM intact or BACE-cleaved peptides are shown in Figure 3 . These spectra show emission from both the donor and the acceptor, as measured on a Tecan Safire 2 ™ microplate reader. In a typical assay setup, the sensitized emission from the fluorescein acceptor (centered between the first 2 terbium emission peaks, from approximately 507 nm to 532 nm) is measured and divided by ("ratioed" with) the signal from the 1st terbium emission peak (centered at 490 nm). Reactions using 1a were incubated with 1 nM streptavidin or antibiotin antibody that had been randomly labeled via surface-accessible amino groups (on average, 4 or 8 Tb chelates per protein, respectively). When 1a was indirectly labeled with Tb-streptavidin or Tb-antibiotin antibody, the efficiency of RET was higher for the Tb-streptavidin sample (as seen by the amount of sensitized emission relative to donor emission), but the intensity of sensitized emission was substantially lower than seen with the sample labeled using the Tb-antibiotin antibody, even when accounting for the higher number of terbium chelates per antibody relative to the number of terbium chelates per streptavidin. The intensity of sensitized emission from the fluorescein acceptor in 1b was negligible.
Sensitized emission decays monitoring the RET-dependent sensitized emission from fluorescein in these samples were measured using a BMG Pherastar microplate reader and are shown in Figure 4 . As predicted in the model, samples in which the donor-acceptor pair is spaced at substantially less than the Förster radius show greatly decreased sensitized emission lifetimes. In a typical LRET-based protease assay measuring donor and acceptor intensities in a gated detection mode, this results in a substantially reduced measured signal. Sensitized emission from fluorescein in the intact, directly labeled peptide 1b rapidly decayed to within the baseline noise and could not be detected in a gated detection mode. The sensitized emission decay of fluorescein from 1a labeled with Tb-streptavidin was also rapid but was detectable from background. The rate of decay of sensitized fluorescein emission from 1a labeled with Tb-antibiotin antibody was substantially slower, and thus the integrated signal that was measured was substantially higher than that from the other samples.
Because the antibody and streptavidin are randomly labeled with multiple Tb chelates, the observed emission decays are due to a mixed population of donor-acceptor pairs, some of which transfer energy too rapidly to measure in a gated detection format, some of which do not substantially contribute to sensitized emission, and some of which have lifetimes that are ideally measured in a gated detection format. In addition, because streptavidin contains 4 biotin binding sites, the average donor-acceptor distance is reduced relative to an antibodybased system containing 2 binding sites through which acceptor can associate. When a sample of intact peptide was titrated into Tb-streptavidin ( Fig. 5) , terbium emission was quenched in a peptide-dependent manner, but the sensitized emission from fluorescein increased and then decreased. When Tbstreptavidin is subsaturated with peptide, there exist donoracceptor pairs that are spaced such that sensitized emission is readily detectable. However, as the Tb-streptavidin becomes saturated, all terbium chelates are within closer proximity to a fluorescein acceptor. In this state, energy transfer efficiency is maximal (as seen by the maximally decreased terbium emission) but too rapid for the sensitized emission from fluorescein to be effectively measured. It is also interesting to note that when using the directly labeled or Tb-streptavidin-labeled peptide, sensitized emission actually increases upon substrate proteolysis due to diffusion-enhanced RET that takes place when the donor and acceptor are able to diffuse to within proximity of one another during the excited state lifetime of the donor species. 12 HTS assays are typically performed in plastic microplates using a flashlamp excitation source, and signals due to the noninstantaneous nature ("tailing") of the flashlamp pulse as well as autofluorescence from the plastic itself preclude gating on a timescale fast enough to capture the rapidly decaying sensitized emission signal from a directly labeled peptide such as 1b. Although protease assays using such substrates have been described, 13, 14 the high efficiency of energy transfer prevents measurement of acceptor and donor signals that can be referenced ("ratioed") to one another. Although such assays are well suited for detailed kinetic or mechanistic studies, ratiometric fluorescence measurements have well-described advantages in HTS applications by correcting for optical effects, such as absorbance of incident excitation light by compounds that absorb in the UV region. 4 In summary, we have shown that by increasing the average donor-acceptor distance in an LRET-based assay system, the intensity of measured sensitized emission can be substantially increased, improving assay quality. This is counter to an intuitive assumption that RET-based assays can be improved by increasing energy transfer and should therefore be designed to minimize donor-acceptor distances. Although this is correct for nongated intensity measurements using short-lifetime fluorophores, it does not hold true in gated intensity measurements in which efficient energy transfer can lead to transfer being complete prior to detection. Journal of Biomolecular Screening 11(4); 2006 In the absence of resonance energy transfer (RET), the donor signal is high, and the sensitized emission of the fluorescein acceptor is low. (C) When Tb-streptavidin is subsaturated, energy transfer takes place between donors and acceptors such that some fraction of the transfer is on the timescale that it can be measured within the gated detection window, causing an increase in sensitized emission from fluorescein. (D) As the Tb-streptavidin becomes saturated, all energy transfer is rapid, and sensitized emission cannot be efficiently measured within the gated detection window. Although energy transfer efficiency is maximal, the result is a decrease in apparent (measured) sensitized emission.
